Adobe PDF Format
There is over three years to go until the next Ofwat price review “PR14” but cost pressures won’t wait:
Absorbing any or all of these costs will mean sacrificing return, will impact shareholder value and could impinge on your financeability at a time when capital markets are increasingly nervous and uncompromising.
To reduce your exposure PwC can help you with deciding upon the merits of an IDoK and support you with stating your case to Ofwat in a compelling and well justified way.